Summary Alcresta Therapeutics Inc (Alcresta) develops and commercializes enzyme-based products for the treatment of gastrointestinal disorders and rare diseases.The company’s proprietary technology platform supports a pipeline of products that results in malabsorption common in cystic fibrosis, digestive cancers, and other serious diseases.
It offers iLipase, to develop and market a range of novel, point of care, enzyme based products to support nutrition.Alcrestad’siLipase increases the absorption of fats crucial for growth and development, and improves the delivery, digestion and absorption of critical nutrients.
The company also develops products indicated for exocrine pancreatic insufficiency caused by cystic fibrosis and other serious diseases.It caters to consumer and nutritional care markets.
Alcresta is headquartered in Newton, Massachusetts, the US.
Alcresta Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The ePRO, ePatient Diaries, and eCOA market in Middle East and Africa is expected to grow from US$ 48.4 million in 2021 to US$ 112.3 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. Mobile-enabled...
The ePRO, ePatient Diaries, and eCOA market in South and Central America is expected to grow from US$ 90.3 million in 2021 to US$ 229.0 million by 2028; it is estimated to grow at a CAGR of 14.2% from 2021 to 2028. Patient centricity means designing a treatment, clinical trial, or other health solution centered around the patient. Creating...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
The ePRO, ePatient Diaries, and eCOA market in North America is expected to grow from US$ 607.2 million in 2021 to US$ 1,640.6 million by 2028; it is estimated to grow at a CAGR of 15.3% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. As per the...
2021 Orthopedics Market Analysis, Global Forecasts, Competitive Landscape--Accelerated Rate of Change and Regulatory Uncertainty--Performance, Capabilities, Goals and Strategies of Leading Suppliers
I. Top 10 Orthopedic Companies
Aesculap, Arthrex, DePuy Synthes, Globus Medical, Medtronic,...
This report focuses on types of healthcare information technology such as electronic health records, provider order entry systems, electronic prescribing systems, picture archiving and communication systems, laboratory information systems, clinical decision systems, and telemedicine.The report covers the market...
This IDC study discusses how healthcare organizations are on a mission to digitally transform to create a value-based healthcare system, even though they may not use the term digital transformation as extensively as other industries such as retail or financial services do. While the pandemic drove unprecedented adoption of virtual visits and...
The global cochlear implants market exhibited strong growth during 2015-2020. A cochlear implant is an electronic device that is surgically placed in the ears for producing useful hearing sensations. It is implanted in the inner ear of individuals with severe to profound nerve deafness. The device consists of a microphone,...
Diaphragm Pressure Gauges Market Report - Global Industry Data, Analysis and Growth Forecasts by Type, Application and Region, 2021-2028 Diaphragm Pressure Gauges market overview – The traditional sensors market is moving towards smart sensors and illustrates an attractive growth rate during the...
Mechanical Flowmeters Market Report - Global Industry Data, Analysis and Growth Forecasts by Type, Application and Region, 2021-2028 Mechanical Flowmeters market overview – The traditional sensors market is moving towards smart sensors and illustrates an attractive growth rate during the forecast...
Supply Chain Management
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.